한글목차

조혈모세포 이식(HSCT) 시장은 2023-2028년간 25억 8,510만 달러 확대되고, 예측 기간 중 연평균 복합 성장률(CAGR)은 6.64%를 나타낼 전망입니다.

조혈모세포 이식(HSCT) 시장에 대한 전체적인 분석, 시장 규모와 예측, 동향, 성장 촉진요인, 과제, 약 25개 벤더를 대상으로 한 벤더 분석 등의 정보를 게재했습니다.

현재의 시장 시나리오, 최신 동향과 촉진요인, 시장 환경 전체에 관한 최신 분석을 제공합니다. 기술적으로 첨단기기 이용 가능성, 재생의료 분야에 대한 투자 증가, 조혈모세포 이식 건수 증가에 의해 시장 성장이 촉진되고 있습니다.

본 조사에서는 향후 몇 년간 조혈모세포 이식(HSCT) 시장 성장을 가속하는 주요인 중 하나로서 맞춤형 의료에 대한 수요 증가를 들고 있습니다. 또한 이환율이나 사망률 저하, 제대혈 은행의 출현도 시장의 큰 수요로 연결될 것입니다.

목차

제1장 주요 요약

• 시장 개요

제2장 시장 구도

• 시장 생태계
• 시장 특징
• 밸류체인 분석

제3장 시장 규모 평가

• 시장의 정의
• 시장 부문 분석
• 시장 규모(2023년)
• 시장 전망(2023-2028년)

제4장 시장 규모 실적

• 세계의 조혈모세포 이식(HSCT) 시장(2018-2022년)
• 용도별 부문 분석(2018-2022년)
• 유형별 부문 분석(2018-2022년)
• 지역별 부문 분석(2018-2022년)
• 국가별 부문 분석(2018-2022년)

제5장 Five Forces 분석

• Five Forces 요약
• 바이어의 교섭력
• 공급 기업의 교섭력
• 신규 진출업체의 위협
• 대체품의 위협
• 경쟁 위협
• 시장 현황

제6장 시장 세분화 : 용도별

• 시장 세분화
• 비교 : 용도별
• 골수 이식 : 시장 규모와 예측(2023-2028년)
• 말초혈 줄기세포 이식 : 시장 규모와 예측(2023-2028년)
• 제대혈 이식 : 시장 규모와 예측(2023-2028년)
• 시장 기회 : 용도별

제7장 시장 세분화 : 유형별

• 시장 세분화
• 비교 : 유형별
• 자가 조혈모세포 이식 : 시장 규모와 예측(2023-2028년)
• 동종 조혈모세포 이식 : 시장 규모와 예측(2023-2028년)
• 시장 기회 : 유형별

제8장 고객 상황

• 고객 상황 개요

제9장 지역별 상황

• 지역별 세분화
• 지역별 비교
• 북미 : 시장 규모와 예측(2023-2028년)
• 유럽 : 시장 규모와 예측(2023-2028년)
• 아시아 : 시장 규모와 예측(2023-2028년)
• 세계 기타 지역 : 시장 규모와 예측(2023-2028년)
• 미국 : 시장 규모와 예측(2023-2028년)
• 영국 : 시장 규모와 예측(2023-2028년)
• 캐나다 : 시장 규모와 예측(2023-2028년)
• 독일 : 시장 규모와 예측(2023-2028년)
• 중국 : 시장 규모와 예측(2023-2028년)
• 시장 기회 : 지역별

제10장 성장 촉진요인, 과제, 기회 및 억제요인

• 시장 성장 촉진요인
• 시장이 해결해야 할 과제
• 성장 촉진요인과 과제의 영향
• 시장 기회 및 성장 억제요인

제11장 경쟁 구도

• 개요
• 경쟁 구도
• 혼란 상황
• 업계 리스크

제12장 경쟁 분석

• 기업 개요
• 기업의 시장 포지셔닝
• AllCells Corp.
• Athersys Inc.
• Beike Biotechnology Co. Ltd.
• bluebird bio Inc.
• Cellular Biomedicine Group Inc.
• FUJIFILM Corp.
• Gamida Cell Ltd.
• Lineage Cell Therapeutics Inc.
• Lonza Group Ltd.
• MEDIPOST Co. Ltd.
• Merck and Co. Inc.
• Mesoblast Ltd.
• Sanofi SA
• Takeda Pharmaceutical Co. Ltd.
• ThermoGenesis Holdings Inc.

제13장 부록

영문목차

The hematopoietic stem cells transplantation (HSCT) market is forecasted to grow by USD 2585.1 mn during 2023-2028, accelerating at a CAGR of 6.64% during the forecast period. The report on the hematopoietic stem cells transplantation (HSCT) market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by availability of technologically advanced equipment, increasing investments in field of regenerative medicines, and rising number of HSCT.

Technavio's hematopoietic stem cells transplantation (HSCT) market is segmented as below:

By Application

• Bone marrow transplant
• Peripheral blood stem cell transplant
• Cord blood transplant

By Type

• Autologous HSCT
• Allogeneic HSCT

By Geography

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the growing demand for personalized medicine as one of the prime reasons driving the hematopoietic stem cells transplantation (HSCT) market growth during the next few years. Also, decreasing morbidity and mortality rate and advent of cord blood banking will lead to sizable demand in the market.

The report on the hematopoietic stem cells transplantation (HSCT) market covers the following areas:

• Hematopoietic stem cells transplantation (HSCT) market sizing
• Hematopoietic stem cells transplantation (HSCT) market forecast
• Hematopoietic stem cells transplantation (HSCT) market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading hematopoietic stem cells transplantation (hsct) market vendors that include AllCells Corp., Athersys Inc., Beike Biotechnology Co. Ltd., bluebird bio Inc., Cellular Biomedicine Group Inc., FUJIFILM Corp., Gamida Cell Ltd., Lineage Cell Therapeutics Inc., Lonza Group Ltd., MEDIPOST Co. Ltd., Merck and Co. Inc., Mesoblast Ltd., Pluristem Therapeutics Inc., Sanofi SA, Sartorius CellGenix GmbH, Taiga Biotechnologies Inc., Takeda Pharmaceutical Co. Ltd., Talaris Therapeutics Inc., and ThermoGenesis Holdings Inc.. Also, the hematopoietic stem cells transplantation (HSCT) market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market by Geography
  • Executive Summary - Chart on Market Segmentation by Application
  • Executive Summary - Chart on Market Segmentation by Type
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
  • Parent Market
  • Data Table on - Parent Market
• 2.2 Market characteristics
  • Market characteristics analysis
• 2.3 Value chain analysis
  • Value Chain Analysis

3 Market Sizing

• 3.1 Market definition
  • Offerings of companies included in the market definition
• 3.2 Market segment analysis
  • Market segments
• 3.3 Market size 2023
• 3.4 Market outlook: Forecast for 2023-2028
  • Chart on Global - Market size and forecast 2023-2028 ($ million)
  • Data Table on Global - Market size and forecast 2023-2028 ($ million)
  • Chart on Global Market: Year-over-year growth 2023-2028 (%)
  • Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

• 4.1 Global Hematopoietic Stem Cells Transplantation (HSCT) Market 2018 - 2022
  • Historic Market Size - Data Table on Global Hematopoietic Stem Cells Transplantation (HSCT) Market 2018 - 2022 ($ million)
• 4.2 Application segment analysis 2018 - 2022
  • Historic Market Size - Application Segment 2018 - 2022 ($ million)
• 4.3 Type segment analysis 2018 - 2022
  • Historic Market Size - Type Segment 2018 - 2022 ($ million)
• 4.4 Geography segment analysis 2018 - 2022
  • Historic Market Size - Geography Segment 2018 - 2022 ($ million)
• 4.5 Country segment analysis 2018 - 2022
  • Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

• 5.1 Five forces summary
  • Five forces analysis - Comparison between 2023 and 2028
• 5.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2023 and 2028
• 5.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• 5.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2023 and 2028
• 5.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2023 and 2028
• 5.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2023 and 2028
• 5.7 Market condition
  • Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Application

• 6.1 Market segments
  • Chart on Application - Market share 2023-2028 (%)
  • Data Table on Application - Market share 2023-2028 (%)
• 6.2 Comparison by Application
  • Chart on Comparison by Application
  • Data Table on Comparison by Application
• 6.3 Bone marrow transplant - Market size and forecast 2023-2028
  • Chart on Bone marrow transplant - Market size and forecast 2023-2028 ($ million)
  • Data Table on Bone marrow transplant - Market size and forecast 2023-2028 ($ million)
  • Chart on Bone marrow transplant - Year-over-year growth 2023-2028 (%)
  • Data Table on Bone marrow transplant - Year-over-year growth 2023-2028 (%)
• 6.4 Peripheral blood stem cell transplant - Market size and forecast 2023-2028
  • Chart on Peripheral blood stem cell transplant - Market size and forecast 2023-2028 ($ million)
  • Data Table on Peripheral blood stem cell transplant - Market size and forecast 2023-2028 ($ million)
  • Chart on Peripheral blood stem cell transplant - Year-over-year growth 2023-2028 (%)
  • Data Table on Peripheral blood stem cell transplant - Year-over-year growth 2023-2028 (%)
• 6.5 Cord blood transplant - Market size and forecast 2023-2028
  • Chart on Cord blood transplant - Market size and forecast 2023-2028 ($ million)
  • Data Table on Cord blood transplant - Market size and forecast 2023-2028 ($ million)
  • Chart on Cord blood transplant - Year-over-year growth 2023-2028 (%)
  • Data Table on Cord blood transplant - Year-over-year growth 2023-2028 (%)
• 6.6 Market opportunity by Application
  • Market opportunity by Application ($ million)
  • Data Table on Market opportunity by Application ($ million)

7 Market Segmentation by Type

• 7.1 Market segments
  • Chart on Type - Market share 2023-2028 (%)
  • Data Table on Type - Market share 2023-2028 (%)
• 7.2 Comparison by Type
  • Chart on Comparison by Type
  • Data Table on Comparison by Type
• 7.3 Autologous HSCT - Market size and forecast 2023-2028
  • Chart on Autologous HSCT - Market size and forecast 2023-2028 ($ million)
  • Data Table on Autologous HSCT - Market size and forecast 2023-2028 ($ million)
  • Chart on Autologous HSCT - Year-over-year growth 2023-2028 (%)
  • Data Table on Autologous HSCT - Year-over-year growth 2023-2028 (%)
• 7.4 Allogeneic HSCT - Market size and forecast 2023-2028
  • Chart on Allogeneic HSCT - Market size and forecast 2023-2028 ($ million)
  • Data Table on Allogeneic HSCT - Market size and forecast 2023-2028 ($ million)
  • Chart on Allogeneic HSCT - Year-over-year growth 2023-2028 (%)
  • Data Table on Allogeneic HSCT - Year-over-year growth 2023-2028 (%)
• 7.5 Market opportunity by Type
  • Market opportunity by Type ($ million)
  • Data Table on Market opportunity by Type ($ million)

8 Customer Landscape

• 8.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation
  • Chart on Market share By Geographical Landscape2023-2028 (%)
  • Data Table on Market share By Geographical Landscape2023-2028 (%)
• 9.2 Geographic comparison
  • Chart on Geographic comparison
  • Data Table on Geographic comparison
• 9.3 North America - Market size and forecast 2023-2028
  • Chart on North America - Market size and forecast 2023-2028 ($ million)
  • Data Table on North America - Market size and forecast 2023-2028 ($ million)
  • Chart on North America - Year-over-year growth 2023-2028 (%)
  • Data Table on North America - Year-over-year growth 2023-2028 (%)
• 9.4 Europe - Market size and forecast 2023-2028
  • Chart on Europe - Market size and forecast 2023-2028 ($ million)
  • Data Table on Europe - Market size and forecast 2023-2028 ($ million)
  • Chart on Europe - Year-over-year growth 2023-2028 (%)
  • Data Table on Europe - Year-over-year growth 2023-2028 (%)
• 9.5 Asia - Market size and forecast 2023-2028
  • Chart on Asia - Market size and forecast 2023-2028 ($ million)
  • Data Table on Asia - Market size and forecast 2023-2028 ($ million)
  • Chart on Asia - Year-over-year growth 2023-2028 (%)
  • Data Table on Asia - Year-over-year growth 2023-2028 (%)
• 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
  • Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• 9.7 US - Market size and forecast 2023-2028
  • Chart on US - Market size and forecast 2023-2028 ($ million)
  • Data Table on US - Market size and forecast 2023-2028 ($ million)
  • Chart on US - Year-over-year growth 2023-2028 (%)
  • Data Table on US - Year-over-year growth 2023-2028 (%)
• 9.8 UK - Market size and forecast 2023-2028
  • Chart on UK - Market size and forecast 2023-2028 ($ million)
  • Data Table on UK - Market size and forecast 2023-2028 ($ million)
  • Chart on UK - Year-over-year growth 2023-2028 (%)
  • Data Table on UK - Year-over-year growth 2023-2028 (%)
• 9.9 Canada - Market size and forecast 2023-2028
  • Chart on Canada - Market size and forecast 2023-2028 ($ million)
  • Data Table on Canada - Market size and forecast 2023-2028 ($ million)
  • Chart on Canada - Year-over-year growth 2023-2028 (%)
  • Data Table on Canada - Year-over-year growth 2023-2028 (%)
• 9.10 Germany - Market size and forecast 2023-2028
  • Chart on Germany - Market size and forecast 2023-2028 ($ million)
  • Data Table on Germany - Market size and forecast 2023-2028 ($ million)
  • Chart on Germany - Year-over-year growth 2023-2028 (%)
  • Data Table on Germany - Year-over-year growth 2023-2028 (%)
• 9.11 China - Market size and forecast 2023-2028
  • Chart on China - Market size and forecast 2023-2028 ($ million)
  • Data Table on China - Market size and forecast 2023-2028 ($ million)
  • Chart on China - Year-over-year growth 2023-2028 (%)
  • Data Table on China - Year-over-year growth 2023-2028 (%)
• 9.12 Market opportunity by geography
  • Market opportunity By Geographical Landscape($ million)
  • Data Tables on Market opportunity By Geographical Landscape($ million)

10 Drivers, Challenges, and Opportunity/Restraints

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2023 and 2028
• 10.4 Market opportunities/restraints

11 Competitive Landscape

• 11.1 Overview
• 11.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 11.3 Landscape disruption
  • Overview on factors of disruption
• 11.4 Industry risks
  • Impact of key risks on business

12 Competitive Analysis

• 12.1 Companies profiled
  • Companies covered
• 12.2 Market positioning of companies
  • Matrix on companies position and classification
• 12.3 AllCells Corp.
  • AllCells Corp. - Overview
  • AllCells Corp. - Product / Service
  • AllCells Corp. - Key offerings
• 12.4 Athersys Inc.
  • Athersys Inc. - Overview
  • Athersys Inc. - Product / Service
  • Athersys Inc. - Key offerings
• 12.5 Beike Biotechnology Co. Ltd.
  • Beike Biotechnology Co. Ltd. - Overview
  • Beike Biotechnology Co. Ltd. - Product / Service
  • Beike Biotechnology Co. Ltd. - Key offerings
• 12.6 bluebird bio Inc.
  • bluebird bio Inc. - Overview
  • bluebird bio Inc. - Product / Service
  • bluebird bio Inc. - Key offerings
• 12.7 Cellular Biomedicine Group Inc.
  • Cellular Biomedicine Group Inc. - Overview
  • Cellular Biomedicine Group Inc. - Product / Service
  • Cellular Biomedicine Group Inc. - Key offerings
• 12.8 FUJIFILM Corp.
  • FUJIFILM Corp. - Overview
  • FUJIFILM Corp. - Business segments
  • FUJIFILM Corp. - Key news
  • FUJIFILM Corp. - Key offerings
  • FUJIFILM Corp. - Segment focus
• 12.9 Gamida Cell Ltd.
  • Gamida Cell Ltd. - Overview
  • Gamida Cell Ltd. - Product / Service
  • Gamida Cell Ltd. - Key offerings
• 12.10 Lineage Cell Therapeutics Inc.
  • Lineage Cell Therapeutics Inc. - Overview
  • Lineage Cell Therapeutics Inc. - Product / Service
  • Lineage Cell Therapeutics Inc. - Key offerings
• 12.11 Lonza Group Ltd.
  • Lonza Group Ltd. - Overview
  • Lonza Group Ltd. - Business segments
  • Lonza Group Ltd. - Key news
  • Lonza Group Ltd. - Key offerings
  • Lonza Group Ltd. - Segment focus
• 12.12 MEDIPOST Co. Ltd.
  • MEDIPOST Co. Ltd. - Overview
  • MEDIPOST Co. Ltd. - Product / Service
  • MEDIPOST Co. Ltd. - Key offerings
• 12.13 Merck and Co. Inc.
  • Merck and Co. Inc. - Overview
  • Merck and Co. Inc. - Business segments
  • Merck and Co. Inc. - Key news
  • Merck and Co. Inc. - Key offerings
  • Merck and Co. Inc. - Segment focus
• 12.14 Mesoblast Ltd.
  • Mesoblast Ltd. - Overview
  • Mesoblast Ltd. - Product / Service
  • Mesoblast Ltd. - Key offerings
• 12.15 Sanofi SA
  • Sanofi SA - Overview
  • Sanofi SA - Business segments
  • Sanofi SA - Key news
  • Sanofi SA - Key offerings
  • Sanofi SA - Segment focus
• 12.16 Takeda Pharmaceutical Co. Ltd.
  • Takeda Pharmaceutical Co. Ltd. - Overview
  • Takeda Pharmaceutical Co. Ltd. - Product / Service
  • Takeda Pharmaceutical Co. Ltd. - Key news
  • Takeda Pharmaceutical Co. Ltd. - Key offerings
• 12.17 ThermoGenesis Holdings Inc.
  • ThermoGenesis Holdings Inc. - Overview
  • ThermoGenesis Holdings Inc. - Product / Service
  • ThermoGenesis Holdings Inc. - Key offerings

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 13.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 13.4 Research methodology
  • Research methodology
• 13.5 Data procurement
  • Information sources
• 13.6 Data validation
  • Data validation
• 13.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 13.8 Data synthesis
  • Data synthesis
• 13.9 360 degree market analysis
  • 360 degree market analysis
• 13.10 List of abbreviations
  • List of abbreviations